• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form S-3/A filed by SiNtx Technologies Inc.

    12/9/25 5:01:07 PM ET
    $SINT
    Medical/Dental Instruments
    Health Care
    Get the next $SINT alert in real time by email
    S-3/A 1 forms-3a.htm S-3/A

     

    As filed with the Securities and Exchange Commission on December 9, 2025

     

    Registration No. 333-290628

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    PRE-EFFECTIVE AMENDMENT NO. 1 TO

    FORM S-3

    REGISTRATION STATEMENT

    UNDER

    THE SECURITIES ACT OF 1933

     

    SINTX Technologies, Inc.

    (Exact name of registrant as specified in its charter)

     

    Delaware   84-1375299

    (State or other jurisdiction of

    incorporation or organization)

     

    (I.R.S. Employer

    Identification Number)

     

    1885 West 2100 South

    Salt Lake City, UT 84119

    (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

     

    Eric Olson

    President and Chief Executive Officer

    SINTX Technologies, Inc.

    1885 West 2100 South

    Salt Lake City, UT, 84119

    (801) 839-3500

    (Name, address, including zip code, and telephone number, including area code, of agent for service)

     

    Copies to:

     

    David F. Marx

    Daniel P. Lyman

    Dorsey & Whitney LLP

    111 South Main Street, Suite 2100

    Salt Lake City, Utah 84111

     

     

    Approximate date of commencement of proposed sale to the public: From time to time after the effective date of this Registration Statement as determined by the Selling Stockholder.

     

    If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box: ☐

     

    If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box: ☒

     

    If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering: ☐

     

    If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

     

    If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☐

     

    If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer ☐ Accelerated filer ☐
    Non-accelerated filer ☒ Smaller reporting company ☒
        Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

     

     

     

    The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment that specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.

     

     

     

     
     

     

    EXPLANATORY NOTE

     

    SINTX Technologies, Inc. (the “Company”) is filing this Pre-Effective Amendment No. 1 (the “Amendment”) to its Registration Statement on Form S-3 (Registration No. 333-290628) (the “Registration Statement”) as an exhibits-only filing to file an updated auditor consent in Exhibit 23.1. Accordingly, this Amendment consists only of the facing page, this explanatory note, Item 16 of Part II of the Registration Statement, including the signature page and the exhibit index, and the filed exhibits. The prospectus is unchanged and has been omitted.

     

    Effective October 31, 2025, Tanner LLC converted to Tanner LLP. Effective November 7, 2025, Tanner LLP succeeded to the registration status of Tanner LLC, the predecessor firm, following the change in legal structure. The updated auditor consent in Exhibit 23.1 is appropriately provided by Tanner LLP.

     

     
     

     

    Item 16. Exhibits

     

    Exhibit

    Number

      Exhibit Description  

    Filed with
    this

    Report

     

    Incorporated by
    Reference
    herein from

    Form or
    Schedule

      Filing
    Date
      SEC
    File/Reg.
    Number
                         
    2.1   Asset Purchase Agreement by and among Amedica Corporation, CTL Corporation and US Spine Inc. dated as of September 5, 2018       Form 8-K
    (Exhibit 2.1)
      10/5/18   001-33624
                         
    2.2+†   Asset Purchase Agreement by and among SINTX Technologies, Inc. and B4C, LLC, dated July 20, 2021.      

    Form 8-K

    (Exhibit 2.1)

      7/26/21   001-33624
                         
    2.3†   Stock Purchase Agreement      

    Form 8-K

    (Exhibit 2.1)

      7/6/22   001-33624
                         
    4.1   Form of common stock Certificate of the Registrant      

    Amendment No. 3 to Form S-1

    (Exhibit 4.1)

      1/29/14   333-192232
                         
    4.2   Form of Indenture      

    Form S-3

    (Exhibit 4.2)

      3/25/19   333-230492
                         
    4.3   Dealer Manager Warrants issued to Maxim Group LLC on October 17, 2022      

    Form 8-K

    (Exhibit 4.1)

      10/18/22   001-33624
                         
    4.4   Dealer Manager Warrants issued to Ascendiant Capital Markets, LLC on October 17, 2022      

    Form 8-K

    (Exhibit 4.2)

      10/18/22   001-33624
                         
    4.5   Form of Class A Warrant      

    Form 8-K

    (Exhibit 4.3)

      10/18/22   001-33624
                         
    4.6   Form of Class B Warrant      

    Form 8-K

    (Exhibit 4.4)

      10/18/22   001-33624
                         
    4.7   Form of Class C Warrant      

    Form S-1

    (Exhibit 4.13)

      2/7/23   333-269475
                         
    4.8   Form of Pre-Funded Warrant      

    Form S-1

    (Exhibit 4.14)

      2/6/23   333-269475
                         
    4.9   Form of Class D Warrant      

    Form S-1

    (Exhibit 4.15)

      2/7/23   333-269475
                         
    4.10   Form of Placement Agent Warrant      

    Form S-1

    (Exhibit 4.16)

      2/6/23   333-269475
                         
    4.11   Warrant Agency Agreement      

    Form 8-K

    (Exhibit 4.5)

      2/9/23   001-33624
                         
    4.12   Form of Pre-Funded Warrant      

    Form 8-K

    (Exhibit 4.1)

      2/2/24   001-33624
                         
    4.13   Form of Class E Warrant      

    Form 8-K

    (Exhibit 4.2)

      2/2/24   001-33624

     

     
     

     

    4.14   Form of Class F Warrant      

    Form 8-K

    (Exhibit 4.3)

      2/2/24   001-33624
                         
    4.15   Form of Placement Agent Warrant      

    Form 8-K

    (Exhibit 4.4)

      2/2/24   001-33624
                         
    4.16   Form of Warrant Agency Agreement      

    Form 8-K

    (Exhibit 4.5)

      2/2/24   001-33624
                         
    4.17   Form of Senior Indenture, to be entered into between the Registrant and the trustee designated therein      

    Form S-3

    (Exhibit 4.14)

      10/12/23   333-274951
                         
    4.18   Form of Subordinated Indenture, to be entered into between the Registrant and the trustee designated therein      

    Form S-3

    (Exhibit 4.16)

      10/12/23   333-274951
                         
    4.19   Form of Pre-Funded Warrant      

    Form 8-K

    (Exhibit 4.1)

      02/26/25   001-33624
                         
    4.20   Form of Common Warrant      

    Form 8-K

    (Exhibit 4.2)

      02/26/25   001-33624
                         
    4.21   Form of Placement Agent Warrant      

    Form 8-K

    (Exhibit 4.3)

      02/26/25   001-33624
                         
    4.22   Form of New Warrant       Form 8-K (Exhibit 10.2)   09/09/25   001-33624
                         
    4.23   Form of Placement Agent Warrant       Form 8-K (Exhibit 10.3)   09/09/25   001-33624
                         
    4.24   Form of Additional Placement Agent Warrant       Form 8-K (Exhibit 10.4)   09/09/25   001-33624
                         
    5.1   Opinion of Dorsey & Whitney LLP      

    Form S-3

    (Exhibit 5.1)

      9/30/25   333-290628
                         
    10.1   Form of Purchase Agreement      

    Form 8-K

    (Exhibit 10.1)

      2/26/25   001-33624
                         
    10.2   Form of Registration Rights Agreement      

    Form 8-K

    (Exhibit 10.2)

      2/26/25   001-33624
                         
    23.1   Consent of Independent Registered Public Accounting Firm   X            
                         
    23.2   Consent of Dorsey & Whitney LLP (included in Exhibit 5.1)      

    Form S-3

    (Exhibit 23.2)

       9/30/25   333-290628
                         
    24.1   Power of Attorney      

    Form S-3

    (Exhibit 24.1)

       9/30/25   333-290628
                         
    101   Interactive Data File      

    Form S-3

    (Exhibit 101)

       9/30/25   333-290628
                         
    107   Filing Fee Table      

    Form S-3

    (Exhibit 107)

       9/30/25   333-290628

     

     
     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Salt Lake City, State of Utah, on this 9th day of December, 2025.

     

      SINTX Technologies, Inc.
         
    Date: December 9, 2025 By: /s/ Eric Olson
        Eric Olson
        President and Chief Executive Officer (Principal Executive Officer)

     

    Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

     

    SIGNATURE   TITLE   DATE
             
    /s/ Eric Olson   President, Chief Executive Officer, and Director   December 9, 2025
    Eric Olson   (Principal Executive Officer)    
             
     *   Chief Financial Officer   December 9, 2025
    Kevin Trask   (Principal Financial Officer and Principal Accounting Officer)    
             
     *        
    Jay M. Moyes   Director   December 9, 2025
             
     *        
    Robert D. Mitchell   Director   December 9, 2025
             
     *        
    Gregg Honigblum   Director   December 9, 2025
             
    *        
    Chris Lyons   Director   December 9, 2025
             
    *        
    Mark Anderson   Director   December 9, 2025

     

    * Eric Olson, by signing his name hereto, does hereby sign this document on behalf of each of the persons named above pursuant to the powers of attorney filed with the Securities and Exchange Commission.

     

    By: /s/ Eric Olson  
      Eric Olson  
      President and Chief Executive Officer  

     

     

     

    Get the next $SINT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SINT

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SINT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SINTX Technologies to Participate in Sidoti & Company Investor Conference

    SALT LAKE CITY, Utah, Dec. 08, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), today announced that management will be presenting at Sidoti & Company's Year End Virtual Investor Conference, held December 10-11, 2025. Sidoti's Year End Virtual Investor ConferenceDates: December 10-11, 2025Presentation Date and Time: Wednesday, December 10, 2025 at 3:15 P.M. ETWebcast: https://sidoti.zoom.us/webinar/register/WN_O_OnAvXpQki63dk_9JbUYw To schedule a one-on-one meeting with SINTX Technologies' management team, please email KCSA Strategic Communications at [email protected]. To be added to the Sintx Technologies email distribution list, please email Si

    12/8/25 9:00:00 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

    Milestone enables immediate production of SiN/PEEK custom devices SALT LAKE CITY, Utah, Dec. 01, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics and biomaterials company, today announced that it has signed a supply agreement with Evonik Corporation ("EVONIK"), a global leader in high‑performance polymers, to manufacture the Company's proprietary silicon nitride–PEEK compound (SiN/PEEK) (U.S. Patent No. 10,806,831) engineered for AI‑assisted additive manufacturing of patient‑specific implants that will be produced using equipment already in place at SINTX's U.S.-based production facility. Under the agreement, EVONIK will pr

    12/1/25 8:30:00 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    SINTX Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and Increased Operational Efficiencies

    Company underscores its strengthened liquidity, cost reductions, and first revenue recorded from OsseoSculpt™  SALT LAKE CITY, Utah, Nov. 13, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics and biomaterials company focused on silicon-nitride–based medical technologies, today provided a business update reporting third quarter financial results in conjunction with the filing the Company's Form 10-Q for the quarter ended September 30, 2025. During the third quarter and subsequent weeks, SINTX advanced a focused commercialization plan centered on infection-resistant silicon nitride devices and polymer composites, while tighteni

    11/13/25 8:00:00 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    $SINT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Investment Officer Honigblum Gregg R. bought $34,896 worth of shares (8,200 units at $4.26), increasing direct ownership by 4% to 201,067 units (SEC Form 4)

    4 - Sintx Technologies, Inc. (0001269026) (Issuer)

    12/9/25 8:00:05 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    Chief Investment Officer Honigblum Gregg R. bought $255,350 worth of shares (65,000 units at $3.93) and was granted 53,867 shares, increasing direct ownership by 161% to 192,867 units (SEC Form 4)

    4 - Sintx Technologies, Inc. (0001269026) (Issuer)

    12/8/25 8:00:03 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    Chief Investment Officer Honigblum Gregg R. bought $31,900 worth of shares (10,000 units at $3.19), increasing direct ownership by 16% to 74,000 units (SEC Form 4)

    4 - Sintx Technologies, Inc. (0001269026) (Issuer)

    11/10/25 8:00:06 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    $SINT
    SEC Filings

    View All

    SEC Form EFFECT filed by SiNtx Technologies Inc.

    EFFECT - Sintx Technologies, Inc. (0001269026) (Filer)

    12/12/25 12:15:20 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form S-3/A filed by SiNtx Technologies Inc.

    S-3/A - Sintx Technologies, Inc. (0001269026) (Filer)

    12/9/25 5:01:07 PM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    SiNtx Technologies Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Sintx Technologies, Inc. (0001269026) (Filer)

    12/1/25 8:35:26 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    $SINT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Investment Officer Honigblum Gregg R. bought $34,896 worth of shares (8,200 units at $4.26), increasing direct ownership by 4% to 201,067 units (SEC Form 4)

    4 - Sintx Technologies, Inc. (0001269026) (Issuer)

    12/9/25 8:00:05 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    Chief Investment Officer Honigblum Gregg R. bought $255,350 worth of shares (65,000 units at $3.93) and was granted 53,867 shares, increasing direct ownership by 161% to 192,867 units (SEC Form 4)

    4 - Sintx Technologies, Inc. (0001269026) (Issuer)

    12/8/25 8:00:03 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    Chief Investment Officer Honigblum Gregg R. bought $31,900 worth of shares (10,000 units at $3.19), increasing direct ownership by 16% to 74,000 units (SEC Form 4)

    4 - Sintx Technologies, Inc. (0001269026) (Issuer)

    11/10/25 8:00:06 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    $SINT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by SiNtx Technologies Inc.

    SC 13G/A - Sintx Technologies, Inc. (0001269026) (Subject)

    11/14/24 7:25:52 PM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by SiNtx Technologies Inc.

    SC 13G - Sintx Technologies, Inc. (0001269026) (Subject)

    4/1/24 4:17:43 PM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by SiNtx Technologies Inc. (Amendment)

    SC 13G/A - Sintx Technologies, Inc. (0001269026) (Subject)

    2/13/24 8:12:54 PM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    $SINT
    Financials

    Live finance-specific insights

    View All

    SINTX Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and Increased Operational Efficiencies

    Company underscores its strengthened liquidity, cost reductions, and first revenue recorded from OsseoSculpt™  SALT LAKE CITY, Utah, Nov. 13, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics and biomaterials company focused on silicon-nitride–based medical technologies, today provided a business update reporting third quarter financial results in conjunction with the filing the Company's Form 10-Q for the quarter ended September 30, 2025. During the third quarter and subsequent weeks, SINTX advanced a focused commercialization plan centered on infection-resistant silicon nitride devices and polymer composites, while tighteni

    11/13/25 8:00:00 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market

    Strategic Acquisition Brings Patented Implant Designs, Seasoned Executive Team, and Near-Term Commercial Opportunities SALT LAKE CITY, Utah, June 24, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics company focused on medical device innovation, today announced that it has executed a Definitive Agreement to acquire the surgical business assets of SiNAPTIC Holdings, LLC, a privately held company focused on silicon nitride ceramic manufacturing and innovation. This transaction is a significant milestone in SINTX's strategy to acquire a potential competitor and drive commercial revenue growth and expand its product portfolio in t

    6/24/25 8:30:00 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    SINTX Technologies Acquires Technology Assessment and Transfer, Inc.

    The Acquisition Broadens Opportunities for SINTX in Aerospace, Defense, and Biomedical Markets SALT LAKE CITY, July 06, 2022 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.sintx.com) (NASDAQ:SINT) ("SINTX" or the "Company"), an original equipment manufacturer of advanced ceramics, announced the acquisition of Technology Assessment and Transfer, Inc. (TA&T; https://www.techassess.com/), significantly increasing SINTX's capabilities in the aerospace, defense, and biomedical markets. "We are excited to acquire TA&T and take another step towards diversifying and strengthening SINTX," said Dr. Sonny Bal, President and CEO of SINTX. "TA&T will expand our use of advanced manufacturing techno

    7/6/22 9:00:00 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    $SINT
    Leadership Updates

    Live Leadership Updates

    View All

    SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

    Seasoned Healthcare Executive to Lead Strategic Growth Initiatives Salt Lake City, UT, Nov. 19, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and technical applications, is pleased to announce the appointment of Gregg R. Honigblum as Chief Strategy Officer (CSO). In this role, Mr. Honigblum will oversee driving corporate strategy to support SINTX's growth initiatives and enhancing investor relations. Mr. Honigblum brings over 35 years of experience as an executive for emerging growth companies, specializing in the healthcare secto

    11/19/24 6:00:00 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care